PREreview de Claire Kuziemko
Summary:
This paper explains the methods and results of a randomized, double-blinded placebo-controlled trial of a daily 40,000IU IFN-α nasal spray in cancer patients. The study took place from 2020-2023, with a 90-day treatment period for placebo and treatment groups. The researchers highlight a…